By Manny Jurado, Associate Partner Over 100 million Americans are classified as medically overweight, making obesity one of the fastest growing public health issues in the U.S
Selenium is an essential trace element that is present in high concentrations in the thyrid gland
THE EMERGENCE OF DIABESITY For people of all ages, the risk of Type 2 diabetes rises with increasing body weight and, in rich and developing countries, the prevalence of both obesity and Type 2 diabetes has increased continuously since the 1980s
That's significantly more than typically seen with current treatments like Wegovy or Mounjaro
This article is part of the PlexusDx Education Hub your resource for evidence-based guidance on longevity protocols, peptide therapies, and the genetic variables that shape every metabolic and aging-related decision
The results will support Orexo in establishing strategic partnerships that expand and accelerate the use of this novel delivery method for more efficient treatments options. For further information contact: Nikolaj Srensen, President and CEO Lena Wange, IR & Communications Director Robert Rnn, SVP and Head of R&D Tel: +46 (0)18 780 88 00 E-mail: [email protected] About Orexo Orexo is a Swedish pharmaceutical company with 30 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs
